Skip to main content
. 2019 Feb 20;9:2410. doi: 10.1038/s41598-019-38634-3

Figure 1.

Figure 1

Viability of OC-k3 and HEI-OC1 cell cultures following AG treatments. Selected AGs were applied to the OC-k3 and HEI-OC1 otic cell lines at 2 mM (a) and 5 mM (b). After 48-h, the viability of the cells were determined using the MTT test, comparing the treated cells to the control cells (100%). Data are presented as means ± SD. *p < 0.05; **p < 0.01 (two-tailed unpaired Student’s t-tests used to compare each treatment to controls). (a) 2 mM AGs, OC-k3 cells: GM C1a, p = 0.3; Apra, p = 0.87; GM, p = 0.00000; Paro, p = 0.8; Neo, p = 0.016; (a) 2 mM AGs, HEI-OC1 cells: GM C1a, p = 0.01; Apra, p = 0.18; GM, p = 0.016; Paro, p = 0.051; Neo, p = 1.99E-5; (b) 5 mM AGs, OC-k3 cells: GM C1a, p = 0.003; Apra, p = 0.009; GM, p = 0.01; Paro, p = 0.043; Neo, p = 0.0005; (b) 5 mM AGs, HEI-OC1 cells: GM C1a, p = 0.006; Apra, p = 3.3E-6; GM, p = 0.001; Paro, p = 0.0001; Neo, p = 5.5E-5). Abbreviations: AG, aminoglycoside; Apra, apramycin; GM, gentamicin; GM C1a, gentamicin C1a; MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; Neo, neomycin; Paro, paromomycin.